Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Nephrocare Health Services
Quarter-by-quarter operating performance
| Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 197 | 219 | 246 | 260 | 266 |
| Expenses + | 153 | 168 | 182 | 199 | 215 |
| Operating Profit | 44 | 51 | 64 | 61 | 51 |
| OPM % | 22% | 23% | 26% | 23% | 19% |
| Other Income + | 5 | 4 | 4 | 3 | 12 |
| Interest | 5 | 6 | 45 | 6 | 3 |
| Depreciation | 18 | 19 | 23 | 22 | 26 |
| Profit before tax | 26 | 30 | -1 | 36 | 33 |
| Tax % | 24% | 17% | 1,427% | 11% | 9% |
| Net Profit + | 20 | 25 | -9 | 32 | 30 |
| EPS in Rs | 96.50 | 119.30 | -5.24 | 3.21 | 3.03 |
Financials of Nephrocare Health Services
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 286 | 318 | 437 | 566 | 756 | 999 |
| Expenses + | 248 | 302 | 389 | 465 | 589 | 775 |
| Operating Profit | 37 | 16 | 49 | 101 | 167 | 224 |
| OPM % | 13% | 5% | 11% | 18% | 22% | 22% |
| Other Income + | 5 | 10 | 6 | 8 | 14 | 25 |
| Interest | 7 | 10 | 16 | 20 | 21 | 60 |
| Depreciation | 34 | 42 | 47 | 56 | 72 | 91 |
| Profit before tax | 1 | -27 | -9 | 33 | 87 | 97 |
| Tax % | 31% | -21% | 37% | -6% | 23% | 21% |
| Net Profit + | 1 | -21 | -12 | 35 | 67 | 77 |
| EPS in Rs | 3.40 | -106.93 | -58.69 | 169.82 | 321.87 | 7.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Nephrocare Health Services
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 20 |
| Reserves | 245 | 391 | 384 | 409 | 579 | 1,096 |
| Borrowings + | 140 | 119 | 200 | 271 | 261 | 80 |
| Other Liabilities + | 42 | 59 | 81 | 124 | 153 | 275 |
| Total Liabilities | 428 | 571 | 666 | 806 | 994 | 1,471 |
| Fixed Assets + | 192 | 205 | 239 | 356 | 396 | 517 |
| CWIP | 2 | 43 | 34 | 1 | 6 | 6 |
| Investments | 0 | 0 | 0 | 0 | 51 | 178 |
| Other Assets + | 234 | 322 | 393 | 449 | 542 | 771 |
| Total Assets | 428 | 571 | 666 | 806 | 994 | 1,471 |
Financials of Nephrocare Health Services
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 32 | 14 | 11 | 72 | 135 | 233 |
| Cash from Investing Activity + | -62 | -130 | -76 | -52 | -125 | -410 |
| Cash from Financing Activity + | 36 | 121 | 60 | 27 | 54 | 157 |
| Net Cash Flow | 5 | 6 | -4 | 47 | 65 | -21 |
| Free Cash Flow | -29 | -64 | -62 | -8 | 35 | 113 |
| CFO/OP | 49% | 119% | 14% | 80% | 82% | 116% |
Financials of Nephrocare Health Services
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 101 | 123 | 132 | 131 | 129 | 116 |
| Inventory Days | 65 | 50 | 67 | 53 | ||
| Days Payable | 56 | 70 | 63 | 230 | ||
| Cash Conversion Cycle | 110 | 103 | 137 | 131 | 129 | -61 |
| Working Capital Days | 26 | 55 | 19 | 56 | 27 | 104 |
| ROCE % | -4% | 1% | 8% | 14% | 15% |
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…